Narongroeknawin, P., Chevaisrakul, P., Kasitanon, N., Kitumnuaypong, T., Mahakkanukrauh, A., Siripaitoon, B., & Katchamart, W. (2018). Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry.
Chicago Style CitationNarongroeknawin, Pongthorn, Parawee Chevaisrakul, Nuntana Kasitanon, Tasanee Kitumnuaypong, Ajanee Mahakkanukrauh, Boonjing Siripaitoon, and Wanruchada Katchamart. Drug Survival and Reasons for Discontinuation of the First Biological Disease Modifying Antirheumatic Drugs in Thai Patients With Rheumatoid Arthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry. 2018.
MLA引文Narongroeknawin, Pongthorn, et al. Drug Survival and Reasons for Discontinuation of the First Biological Disease Modifying Antirheumatic Drugs in Thai Patients With Rheumatoid Arthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry. 2018.